Ignite Creation Date:
2024-05-06 @ 6:32 PM
Last Modification Date:
2025-12-17 @ 3:34 AM
Study NCT ID:
NCT05695391
Status:
None
Last Update Posted:
2025-07-09 00:00:00
First Post:
2022-12-21 00:00:00
Brief Title:
A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM
Sponsor:
Laboratoire français de Fractionnement et de Biotechnologies
Organization:
Laboratoire français de Fractionnement et de Biotechnologies
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2022-12-21 00:00:00
First Submit QC Date:
January 12 2023
Study First Post Date:
2023-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-03 00:00:00
Last Update Post Date:
2025-07-09 00:00:00
Last Update Post Date Type:
ACTUAL